China Pharmaceutical Packaging Market Size, Share, Analysis & Trends (2025 - 2030)

The China Pharmaceutical Packaging Market Report is Segmented by Packaging Type (Primary Packaging (Pharmaceutical Plastic Bottles, Bottles and Jars, Blister Packaging, Pre-Fillable Syringes, Vials and Ampoules, Iv Containers, Prefillable Inhalers, and Other Primary Packaging), and Secondary Packaging (Folding Boxes and Cartons (Paper-Based), Corrugated Shipping Containers (Paper-Based), Bags and Pouches (Flexible), Clamshells (Paper and Plastic), and Other Secondary Packaging Products)). The Report Offers Market Forecasts and Size in Value (USD) for all the Above Segments.

China Pharmaceutical Packaging Market Size, Share, Analysis & Trends (2025 - 2030)

China Pharmaceutical Packaging Market Size

China Pharmaceutical Packaging Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 20.84 Billion
Market Size (2030) USD 28.93 Billion
CAGR (2025 - 2030) 6.78 %
Market Concentration Low

Major Players

China Pharmaceutical Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of China Pharmaceutical Packaging Market with other markets in Packaging Industry

Advanced Packaging

Packaging Equipment

Contract Packaging

Overall Packaging

Packaging Customers

Packaging Forms

China Pharmaceutical Packaging Market Analysis

The China Pharmaceutical Packaging Market size is estimated at USD 20.84 billion in 2025, and is expected to reach USD 28.93 billion by 2030, at a CAGR of 6.78% during the forecast period (2025-2030).

The Chinese pharmaceutical packaging industry is experiencing significant transformation driven by evolving healthcare needs and demographic shifts. According to recent World Health Organization data from November 2023, China accounts for approximately 25% of global COPD cases with an estimated 100 million sufferers, highlighting the massive scale of healthcare demands. This growing disease burden is compelling pharmaceutical companies to invest in advanced pharma packaging solutions that ensure drug stability and patient compliance. The industry is witnessing a shift from traditional packaging methods to more sophisticated solutions that incorporate smart technologies and enhanced protection features. The emphasis on quality and safety has led to increased adoption of high-barrier materials and tamper-evident packaging solutions across the pharmaceutical sector.


The aging population in China is creating unprecedented demands on the pharmaceutical packaging industry. According to the National Center for Biotechnology Information, China's elderly population aged 60 and above is projected to surge from 263 million to 522 million between 2020 and 2050. This demographic shift is driving innovations in packaging design, including easy-open containers, larger print sizes, and smart packaging solutions that enhance medication adherence. Manufacturers are responding by developing specialized packaging that addresses the unique needs of elderly consumers while maintaining product integrity and safety.


The industry is witnessing a significant shift towards sustainable and environmentally responsible packaging solutions. Manufacturers are increasingly adopting eco-friendly materials and implementing green manufacturing practices to reduce environmental impact. This transformation is particularly evident in the rising adoption of recyclable materials and the development of biodegradable packaging alternatives. The integration of nanotechnology and smart packaging solutions is enabling real-time monitoring of product conditions, ensuring better quality control and patient safety throughout the supply chain.


China's robust export growth is reshaping the pharmaceutical packaging landscape. According to China Customs data published in January 2024, the country's export value reached approximately USD 3380.02 billion in 2023, reflecting strong international trade momentum. This has spurred domestic manufacturers to enhance their production capabilities and quality standards to meet global requirements. Major industry players are expanding their facilities and implementing advanced technologies to strengthen their competitive position in the international market. For instance, in September 2023, Sanner Group announced an 80% expansion of its production capacity with a new manufacturing facility in Kunshan, demonstrating the industry's commitment to meeting growing global demand.

Segment Analysis: By Primary Packaging

Vials and Ampoules Segment in China Pharmaceutical Packaging Market

Vials and ampoules dominate the Chinese pharmaceutical primary packaging market, commanding approximately 35% market share in 2024. This segment's leadership position is driven by the increasing demand for medications and vaccinations, particularly as manufacturers of pharmaceutical vials and pharmaceutical ampoules packaging have significantly expanded their production capacity. The segment's prominence is further reinforced by the growing investment in healthcare systems and rising drug spending across China. Glass vials and ampoules are increasingly preferred due to their durability, non-reactivity, transparency, eco-friendliness, and versatility in pharmaceutical applications. Additionally, the segment's growth is supported by continuous technological advancements and innovations in manufacturing processes, ensuring higher quality standards and improved product safety.

Market Analysis of China Pharmaceutical Packaging Market: Chart for By Primary Packaging

Blister Packaging Segment in China Pharmaceutical Packaging Market

The pharmaceutical blister packaging segment is projected to experience the fastest growth rate of approximately 8% during the forecast period 2024-2029. This remarkable growth is primarily attributed to its numerous advantages, including improved product protection, ease of distribution, unit dosage packaging, and enhanced product identification capabilities. The segment's expansion is particularly driven by the rise of OTC medicines and the increasing availability of generic medicines under government health schemes. The growth is further supported by China's position as one of the fastest-growing self-prescribing markets worldwide, coupled with a growing preference for medications for minor ailments. Additionally, the segment benefits from the increasing elderly population and their need for convenient, easy-to-use packaging formats that ensure proper medication adherence.

Remaining Segments in Primary Packaging

The other segments in the pharmaceutical primary packaging market include pharmaceutical bottles, bottles and jars, pre-fillable syringes, IV containers, prefillable inhalers, and other primary packaging products. Pharmaceutical bottles represent a significant portion of the market, driven by their cost-effectiveness and versatility. Pre-fillable syringes are gaining importance due to the increasing focus on self-administered medications and biologics. IV containers continue to serve essential healthcare delivery needs, while prefillable inhalers cater to the growing respiratory medicine market. Each of these segments contributes uniquely to the market's diversity, addressing specific pharmaceutical packaging requirements and evolving healthcare needs.

Segment Analysis: By Secondary Packaging

Folding Boxes & Cartons Segment in China Pharmaceutical Packaging Market

Folding boxes and pharmaceutical cartons dominate the pharmaceutical secondary packaging segment of China's pharmaceutical packaging market, commanding approximately 39% market share in 2024. This segment's leadership position is driven by several key factors, including flexibility, rigidity, and cost-effective flat-pack shipping and storage capabilities. The folding box packaging ensures optimal protection of pharmaceutical products from external factors like light, moisture, and contamination, helping preserve medication potency and integrity. The implementation of radio-frequency identification (RFID) smart labeling technology to prevent product replication has further strengthened this segment's position. Additionally, the rising demand for printed pharmaceutical cartons, driven by industry competition and the need for ample space for regulatory information and brand advertising, continues to fuel the segment's growth. The segment is expected to maintain its dominant position through 2029, growing at the highest rate of around 6% among all pharmaceutical secondary packaging segments, driven by the increasing adoption of blister packaging and the growing need for sturdy and versatile folding carton protection.

Remaining Segments in Secondary Packaging

The secondary packaging market in China is further segmented into bags and pouches, clamshells, corrugated shipping containers, and other secondary packaging products. Bags and pouches offer excellent barrier properties and protection for pharmaceutical and medical devices during storage and transportation. Clamshell packaging provides safe and hygienic solutions for medical equipment packaging with tamper-evident features. Corrugated shipping containers play a crucial role in ensuring product safety during transportation, particularly beneficial for the growing e-commerce pharmaceutical sector. Other secondary packaging products, including trays and labels, contribute to the overall market by providing specialized solutions for specific packaging needs. Each of these segments serves unique purposes in the pharmaceutical packaging industry, from ensuring product integrity to facilitating safe transportation and storage.

China Pharmaceutical Packaging Market Overview

Top Companies in China Pharmaceutical Packaging Market

The Chinese pharmaceutical packaging market features prominent players like Gerresheimer Shuangfeng, West Pharmaceutical Services, Amcor Group, and Shandong Pharmaceutical Glass leading the industry. Companies are increasingly focusing on innovative pharmaceutical packaging solutions, particularly in sustainable materials and smart packaging technologies, to meet evolving market demands. Operational agility is demonstrated through investments in advanced manufacturing facilities and automation, enabling faster responses to market changes and enhanced production efficiency. Strategic moves include vertical integration to strengthen supply chain control and expansion of production capacities across different regions in China. Companies are also pursuing collaborative partnerships for technological advancement, particularly in areas such as 5G-enabled smart manufacturing and cloud-based solutions, while expanding their presence through new facility establishments and strategic acquisitions to capture growing market opportunities.

Market Dominated by Local Manufacturing Specialists

The Chinese pharmaceutical packaging market exhibits a fragmented structure with a mix of global conglomerates and local specialists competing for market share. Local manufacturers dominate the domestic market, leveraging their deep understanding of regional requirements and established relationships with pharmaceutical companies. The market is characterized by the presence of over a thousand pharmaceutical packaging companies, with most focusing on specific product segments such as pharmaceutical glass packaging, blister packaging, or pharmaceutical plastic packaging containers. Global players are increasingly establishing local manufacturing facilities through joint ventures or acquisitions to strengthen their position in the Chinese market, while local players are expanding their capabilities to meet international standards.


The market is witnessing a gradual consolidation trend through strategic acquisitions and partnerships, particularly as larger companies seek to expand their product portfolios and geographic reach. Global players are acquiring local manufacturers to gain immediate market access and local expertise, while domestic companies are forming alliances to enhance their technological capabilities and expand their service offerings. The industry is seeing increased investment in research and development facilities, with companies focusing on developing innovative packaging solutions that meet both local requirements and international standards.

Innovation and Sustainability Drive Future Success

For incumbent players to maintain and increase their market share, focus on technological innovation and sustainable packaging solutions is crucial. Companies are investing in smart packaging technologies, including temperature monitoring systems and anti-counterfeiting features, while also developing eco-friendly packaging materials to meet growing environmental concerns. The ability to offer integrated pharmaceutical packaging solutions, combined with strong technical support and customization capabilities, has become essential for market success. Companies are also strengthening their distribution networks and after-sales service capabilities to enhance customer relationships and maintain a competitive advantage.


Market contenders can gain ground by focusing on niche segments and developing specialized packaging solutions for specific pharmaceutical applications. Success factors include building strong relationships with pharmaceutical manufacturers, investing in quality control systems, and maintaining compliance with evolving regulatory standards. The concentration of end-users in specific regions and the increasing demand for high-quality packaging materials present opportunities for new entrants to establish themselves in specialized market segments. While substitution risk remains low due to strict regulatory requirements, companies must stay ahead of regulatory changes, particularly those related to environmental sustainability and product safety, to maintain their market position.

China Pharmaceutical Packaging Market Leaders

  1. Gerresheimer Shuangfeng Pharmaceutical Glass (Danyang) Co. Ltd (Gerresheimer AG)

  2. West Pharmaceutical Services Inc.

  3. Taishan Xinhua Pharmaceutical Packaging Co. Ltd

  4. Ningbo Zhengli Pharmaceutical Packaging

  5. Amcor Group GMBH

  6. *Disclaimer: Major Players sorted in no particular order
China Pharmaceutical Packaging Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

China Pharmaceutical Packaging Market News

  • November 2023 - SGD Pharma introduced the market's primary packaging glass of lightweight glass bottles. The primary packaging combines the functionality of glass with the look and feel of glass while also reducing the carbon footprint associated with weight reduction. According to the Deputy General Manager of Industrial Operations at SGD Pharma's Zhanjiang plant, these bottles are innovated from the company's Zhanjiang plant in China, representing the high-class performance needed coupled with aesthetics and functionality.
  • October 2023 - The glass pioneer SCHOTT introduced next-generation type I Borosilicate glass tubing. This new product and its associated services will support three key trends in the pharma industry: the development of complex pharmaceuticals, sustainability, and digitalization. Pharmaceutical converters use the company's glass tubing to produce high-quality vials, ampoules, syringes, or cartridges to store simple and complex drugs. In particular, the company sees an increasing demand for biopharmaceutical products in the future, where packaging and materials will need to meet more stringent requirements and regulations.

China Pharmaceutical Packaging Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Ecosystem Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitutes
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Industry Regulations, Policies, and Standards for Pharmaceutical Packaging
  • 4.5 Recent Innovations and New Product Development in the Pharmaceutical Packaging Industry
  • 4.6 Raw Material Analysis

5. MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Regulatory Standards on Packaging and Stringent Norms Against Counterfeit Products
    • 5.1.2 Impact of Nanotechnology due to Innovative and New-generation Packaging Solutions
  • 5.2 Market Restraints
    • 5.2.1 Fluctuations in Raw Material Cost due to Suppliers’ Bargaining Power

6. EMERGING TREND ANALYSIS AND KEY SUCCESS FACTORS

7. MARKET SEGMENTATION

  • 7.1 By Primary Packaging
    • 7.1.1 Pharmaceutical Plastic Bottles
    • 7.1.2 Bottles and Jars
    • 7.1.3 Blister Packaging
    • 7.1.4 Pre-fillable Syringes
    • 7.1.5 Vials and Ampoules
    • 7.1.6 IV Containers
    • 7.1.7 Prefillable Inhalers
    • 7.1.8 Other Primary Packaging Products (Pouches, Tubes, Caps, Closures, Etc.)
  • 7.2 By Secondary Packaging
    • 7.2.1 Folding Boxes and Cartons (Paper-based)
    • 7.2.2 Corrugated Shipping Containers (Paper-based)
    • 7.2.3 Bags and Pouches (Flexible)
    • 7.2.4 Clamshells (Paper and Plastic)
    • 7.2.5 Other Secondary Packaging Products (Trays, Labels among Others)

8. COMPETITIVE LANDSCAPE

  • 8.1 Company Profiles*
    • 8.1.1 Gerresheimer Shuangfeng Pharmaceutical Glass (Danyang) Co. Ltd (Gerresheimer AG)
    • 8.1.2 West Pharmaceutical Services Inc.
    • 8.1.3 Taishan Xinhua Pharmaceutical Packaging Co. Ltd
    • 8.1.4 Ningbo Zhengli Pharmaceutical Packaging
    • 8.1.5 Amcor Group GMBH
    • 8.1.6 Perlen Packaging (Suzhou) Co. Ltd
    • 8.1.7 Shandong Pharmaceutical Glass Co. Ltd
    • 8.1.8 Yuhuan Kang-jia Enterprise Co. Ltd
    • 8.1.9 Dongguan Fukang Plastic Products Co. Ltd
    • 8.1.10 JOTOP Glass
    • 8.1.11 Jiangsu Hanlin Pharmaceutical Packaging
    • 8.1.12 Hangzhou Xunda Packaging Co., Ltd.
    • 8.1.13 Luoyang Dirante Pharmaceutical Packaging Material Co. Ltd
  • 8.2 Share of China Pharmaceutical Packaging Companies in Global Market

9. INVESTMENT OUTLOOK

10. FUTURE OF THE MARKET

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

China Pharmaceutical Packaging Market Industry Segmentation

The study considers revenues accrued from the sales of different pharmaceutical packaging products offered by various vendors operating in the market. The market is tracked in terms of revenue in USD. This report analyzes the factors that impact geopolitical developments in the studied market based on the prevalent base scenarios, key themes, and application of vertical-related demand cycles. The estimates for the Chinese pharmaceutical packaging market include all the costs associated with pharmaceutical packaging solution manufacturing, from raw material procurement to the end-user industry. It includes the cost of material used, the cost of other associated products such as inks and adhesives, closures, and the cost of related services like finishing, printing, labeling and marking, packing, and transporting. The estimates exclude the cost of the content that is or is to be packed inside the pharmaceutical packaging solution.

The Chinese pharmaceutical packaging market is segmented by packaging type (primary packaging (pharmaceutical plastic bottles, bottles and jars, blister packaging, pre-fillable syringes, vials and ampoules, IV containers, prefillable inhalers, and other primary packaging products) and secondary packaging (folding boxes and cartons (paper-based), corrugated shipping containers (paper-based), bags and pouches (flexible), clamshells (paper and plastic), and other secondary packaging products)). The report offers market forecasts and size in value (USD) for all the above segments.

By Primary Packaging Pharmaceutical Plastic Bottles
Bottles and Jars
Blister Packaging
Pre-fillable Syringes
Vials and Ampoules
IV Containers
Prefillable Inhalers
Other Primary Packaging Products (Pouches, Tubes, Caps, Closures, Etc.)
By Secondary Packaging Folding Boxes and Cartons (Paper-based)
Corrugated Shipping Containers (Paper-based)
Bags and Pouches (Flexible)
Clamshells (Paper and Plastic)
Other Secondary Packaging Products (Trays, Labels among Others)
Need A Different Region or Segment?
Customize Now

China Pharmaceutical Packaging Market Research FAQs

How big is the China Pharmaceutical Packaging Market?

The China Pharmaceutical Packaging Market size is expected to reach USD 20.84 billion in 2025 and grow at a CAGR of 6.78% to reach USD 28.93 billion by 2030.

What is the current China Pharmaceutical Packaging Market size?

In 2025, the China Pharmaceutical Packaging Market size is expected to reach USD 20.84 billion.

Who are the key players in China Pharmaceutical Packaging Market?

Gerresheimer Shuangfeng Pharmaceutical Glass (Danyang) Co. Ltd (Gerresheimer AG), West Pharmaceutical Services Inc., Taishan Xinhua Pharmaceutical Packaging Co. Ltd, Ningbo Zhengli Pharmaceutical Packaging and Amcor Group GMBH are the major companies operating in the China Pharmaceutical Packaging Market.

What years does this China Pharmaceutical Packaging Market cover, and what was the market size in 2024?

In 2024, the China Pharmaceutical Packaging Market size was estimated at USD 19.43 billion. The report covers the China Pharmaceutical Packaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Pharmaceutical Packaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

China Pharmaceutical Packaging Market Research

Mordor Intelligence provides comprehensive industry analysis and market outlook for the pharmaceutical packaging market in China, covering crucial aspects such as pharmaceutical primary packaging, pharmaceutical secondary packaging, and specialized solutions like pharmaceutical blister packaging and pharmaceutical glass packaging. The report offers detailed market segmentation, growth forecasts, and competitive analysis of leading players in the pharma packaging sector. All these valuable insights are available in an easy-to-read report PDF format, enabling stakeholders to make informed decisions based on current market trends, industry statistics, and future market projections.
Beyond market research, our consulting expertise extends to specialized areas crucial for the drug packaging industry, including regulatory assessment of packaging materials, technology scouting for innovative pharmaceutical container solutions, and product claims assessment for various pharmaceutical labels and packaging components. We assist clients with new product launch strategies, particularly for sterile pharmaceutical packaging solutions, and provide comprehensive analysis of customer needs and behaviors in the Chinese market. Our team also offers support in identifying and assessing potential partners and suppliers, ensuring compliance with local regulations, and developing effective go-to-market strategies for both pharmaceutical plastic packaging and pharmaceutical flexible packaging solutions.